Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intercostobrachial nerve, also known as the lateral cutaneous branch of the second intercostal nerve, is a peripheral sensory nerve. It originates from the second thoracic spinal nerve (T2) and sometimes receives contributions from T3. The nerve pierces through chest wall muscles including serratus anterior, crosses into the axilla, and supplies sensation to skin overlying parts of the axilla and medial/posterior upper arm. It does not have motor function or branches. Clinically, it is significant because it may be injured during surgical procedures involving the axilla—most notably breast cancer surgeries requiring lymph node removal—leading to numbness or altered sensation in its distribution area. The intercostobrachial nerve can also be intentionally blocked with local anesthetic for certain surgical procedures on the upper limb or chest wall. This structure is not considered a therapeutic molecular target, such as an enzyme or receptor relevant to drug development; rather, it is an anatomical structure important in regional anesthesia and surgical planning.
Nerve blockade by local anesthetics inhibits sensory transmission from its cutaneous territory
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intercostobrachial nerve.